🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

James O’Hearn

City Of Hope National Medical Center

ORCID: 0000-0002-7287-2604

Biochemistry, Genetics and Molecular BiologyChemistryMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma”.

Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/j.clml.2023.05.011

N/A

0.182DataRank · unranked

2 citations

Joycelynne Palmer, Nicole Tsai, Jennifer Simpson, James O’Hearn, Anthony S. Stein +10 more

Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2112006119

N/A

0DataRank · unranked

26 citations

Sharareh Gholamin, Ignacio Moraga, Xin Yang, Supraja Saravanakumar, Joseph R. Cohen +10 more

A phase 1 trial of 8‐chloro‐adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokinetics

Cancer(2023)10.1002/cncr.35077

N/A

0DataRank · unranked

5 citations

Lisa S. Chen, Joycelynne Palmer, Jianying Zhang, Timothy W. Synold, Ralf Buettner +8 more